Zobrazeno 1 - 10
of 218
pro vyhledávání: '"63"'
Publikováno v:
European journal of cancer (Oxford, England : 1990). (2)
Autor:
Qi Zhong, Lingzhao Meng, Pingdong Li, Shuzhou Liu, Jugao Fang, Hongzhi Ma, Meng Lian, Lizhen Hou, Ling Feng, Yunfei Bai
Publikováno v:
Acta Oto-Laryngologica. 138:1146-1153
Backgroud: Induction chemotherapy, as a larynx preservation treatment, has been available for over 20 years. We conducted a retrospective study to evaluate the efficacy of this protocol with taxene, cisplatin and 5-fluorouracil in Chinese patients wi
Autor:
Maximilian Weniger, John Moir, Marko Damm, Laura Maggino, Maximilian Kordes, Jonas Rosendahl, Güralp O. Ceyhan, Stephan Schorn, Daniel Schmid, Jan G. D'Haese, Stephan Böck, Stephan Kruger, Michael Haas, Falk Röder, Marco del Chiaro, Matthias Löhr, Domenico Tamburrino, Gaia Masini, Patrick Maisonneuve, Giuseppe Malleo, Roberto Salvia, Richard Charnley
Publikováno v:
Surgical oncology. 35
Introduction The number of people aged 60 and above will rise from 46 million in 2015 to 157 in 2050 million, exceeding 30% of the population in many western countries. Consequently, the demand for oncological therapy for elderly patients will increa
Autor:
Haluk Demiroglu, Seda Balaban, Ibrahim C. Haznedaroglu, Eylem Eliacik, Tuncay Aslan, Umit Yavuz Malkan, Yahya Buyukasik, Hakan Goker, Nilgun Sayinalp, Osman Özcebe, Kadir Acar, Gursel Gunes, Salih Aksu, Sezgin Etgül
Publikováno v:
Turkish Journal of Hematology
Turkish Journal of Hematology, Vol 33, Iss 4, Pp 281-285 (2016)
Turkish Journal of Hematology, Vol 33, Iss 4, Pp 281-285 (2016)
Many studies reported an improved prognosis in patients with Burkitt's lymphoma obviating the need of stem cell transplantation. However, prognosis of the advanced disease [i.e. Burkitt's cell leukemia (BCL)] has not been reported with current treatm
Autor:
Stanley R. Hamilton, Cathy Eng, Krittiya Korphaisarn, Kanwal Pratap Singh Raghav, Scott Kopetz, David R. Fogelman, Michael J. Overman, David G. Menter, Arvind Dasari, Jenifer S Davis, Imad Shureiqi, Metha Trupti, Van K. Morris, Robert A. Wolff, Bryan K. Kee
Publikováno v:
British Journal of Cancer
Background Signet ring cell carcinoma (SRCC) is a rare subtype of colorectal cancer (CRC). The aim of this study was to characterise the genomic alterations and outcomes of SRCC. Methods Medical records of metastatic CRC (mCRC) patients whose tumours
Autor:
Osman Turkmen, Tolga Tasci, Taner Turan, Derman Basaran, Günsu Kimyon, Alper Karalok, Gökhan Tulunay, Isin Ureyen
Publikováno v:
Tumori Journal. 103:177-181
Objective To define the factors associated with methotrexate (MTX) resistance in patients with low-risk gestational trophoblastic neoplasia (GTN). Methods A total of 63 patients with low-risk GTN according to International Federation of Gynecology an
Autor:
Ashvin Paramanathan, Heather Francis, Benjamin Solomon, David Ball, Linda Mileshkin, Michael Franco, Sarah Kofoed, Marnie Collins
Publikováno v:
Clinical Lung Cancer. 14:508-512
Introduction The standard of care for locoregionally advanced non–small-cell lung cancer is concurrent platinum-based chemoradiation. Many patients relapse, and subsequent systemic treatment may involve platinum-doublet chemotherapy. It is not know
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 90(2)
Objectives After failure of first-line epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) in patients with non-small cell lung cancer (NSCLC) harboring EGFR-activating mutation, platinum based combination chemotherapy is recommen
Autor:
Norihiko Oharu, Patrick Schnell, Keith D. Wilner, Jack Mardekian, Michelle Yu-Kite, Diane D. Wang, Jillian Motyl Rockland, Dongrui R. Lu, Todd VanArsdale, Jennifer M. Tursi, Albert L. Kraus, Cynthia Huang Bartlett, Matthew J. Cotter, Kenneth R. Carson, Jaclyn Decembrino, Sindy T. Kim, Anala Gossai, Tamara Snow
Publikováno v:
Clinical Pharmacology & Therapeutics. 111:302-309
This report examined the benefits and risks of palbociclib plus endocrine therapy (ET) in men with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (MBC). Palbociclib was evaluated usi
Autor:
Sheila A. Conway, Aaron H. Wolfson, Jonathan C. Trent, Deukwoo Kwon, Omar Mahmoud, H. Thomas Temple, John D. Pitcher, Pasquale Benedetto, Austin R. Dosch, Gustavo Fernandez
Publikováno v:
American journal of clinical oncology. 39(5)
PURPOSE The perioperative management of primary extremity soft-tissue sarcomas (ESTS) is multidisciplinary including radiation therapy and chemotherapy (CT). The interplay between these modalities and the relative importance of each remain unclear. O